← FDA Drug Approvals (Drugs@FDA)

EFAVIRENZ

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2024-05-10

Drug application

FDA Application #

ANDA091579

Application type

Abbreviated New Drug Application (Generic)

Brand name

EFAVIRENZ

Generic name

EFAVIRENZ

Active ingredients

EFAVIRENZ

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MACLEODS PHARMS LTD

Manufacturer

Macleods Pharmaceuticals Limited

First approval

2024-05-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown